Drug
Protamine Sulfate
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Fear | 837 | 364.1 | 668.2 | signal |
| 2 | Multi-organ Failure | 441 | 294.5 | 387.3 | signal |
| 3 | Renal Injury | 729 | 284.3 | 470.9 | signal |
| 4 | Anhedonia | 625 | 276.1 | 418.0 | signal |
| 5 | Injury | 971 | 159.1 | 336.7 | signal |
| 6 | Unevaluable Event | 932 | 142.4 | 288.3 | signal |
| 7 | Stress | 585 | 93.7 | 137.0 | signal |
| 8 | Renal Failure | 1,007 | 86.6 | 190.6 | signal |
| 9 | Renal Impairment | 592 | 81.4 | 119.6 | signal |
| 10 | Emotional Distress | 708 | 66.9 | 108.3 | signal |
| 11 | Renal Failure Acute | 180 | 48.0 | 53.1 | signal |
| 12 | Post Procedural Haemorrhage | 44 | 43.2 | 44.2 | signal |
| 13 | Cardiogenic Shock | 46 | 36.9 | 37.9 | signal |
| 14 | Anxiety | 902 | 36.2 | 70.2 | signal |
| 15 | Disability | 47 | 27.2 | 27.9 | signal |
| 16 | Pulmonary Hypertension | 40 | 21.9 | 22.4 | signal |
| 17 | Pain | 1,031 | 19.2 | 42.4 | signal |
| 18 | Depression | 343 | 17.2 | 20.9 | signal |
| 19 | Mucosal Inflammation | 36 | 15.8 | 16.1 | signal |
| 20 | Transfusion | 14 | 15.2 | 15.3 | signal |
| 21 | Nervousness | 69 | 15.0 | 15.6 | signal |
| 22 | Post Procedural Complication | 25 | 14.9 | 15.0 | signal |
| 23 | Ventricular Fibrillation | 14 | 14.4 | 14.5 | signal |
| 24 | Cerebrovascular Accident | 213 | 14.3 | 16.1 | signal |
| 25 | Anaphylactic Reaction | 67 | 13.9 | 14.4 | signal |
| 26 | Coagulopathy | 18 | 12.4 | 12.5 | signal |
| 27 | Disseminated Intravascular Coagulation | 14 | 11.3 | 11.4 | signal |
| 28 | Bronchospasm | 14 | 11.2 | 11.3 | signal |
| 29 | Circulatory Collapse | 15 | 10.0 | 10.1 | signal |
| 30 | Emotional Disorder | 27 | 9.9 | 10.1 | signal |
| 31 | Ventricular Tachycardia | 14 | 9.7 | 9.7 | signal |
| 32 | Renal Tubular Necrosis | 8 | 9.3 | 9.3 | signal |
| 33 | Cardiac Arrest | 67 | 9.2 | 9.6 | signal |
| 34 | No Therapeutic Response | 10 | 9.2 | 9.3 | signal |
| 35 | Mitral Valve Incompetence | 9 | 9.1 | 9.1 | signal |
| 36 | Hypotension | 159 | 9.1 | 9.8 | signal |
| 37 | Bradycardia | 36 | 7.7 | 7.9 | signal |
| 38 | Therapeutic Product Effect Decreased | 30 | 7.7 | 7.8 | signal |
| 39 | Blood Urea Increased | 11 | 7.5 | 7.5 | signal |
| 40 | Mental Disorder | 27 | 7.1 | 7.2 | signal |
| 41 | Adrenal Insufficiency | 7 | 6.7 | 6.7 | signal |
| 42 | Neutrophil Count Increased | 6 | 6.7 | 6.7 | signal |
| 43 | Shock | 13 | 6.5 | 6.5 | signal |
| 44 | Cardiac Disorder | 53 | 6.4 | 6.6 | signal |
| 45 | Myocardial Infarction | 97 | 6.3 | 6.6 | signal |
| 46 | Myocardial Ischaemia | 6 | 6.0 | 6.0 | signal |
| 47 | Cardio-respiratory Arrest | 22 | 6.0 | 6.0 | signal |
| 48 | Death | 448 | 5.9 | 7.5 | signal |
| 49 | Hypotonia | 5 | 5.7 | 5.7 | signal |
| 50 | Coronary Artery Disease | 15 | 5.6 | 5.7 | signal |
| 51 | Generalised Tonic-clonic Seizure | 8 | 5.6 | 5.6 | signal |
| 52 | Unresponsive To Stimuli | 12 | 5.3 | 5.4 | signal |
| 53 | Ischaemic Stroke | 8 | 5.1 | 5.1 | signal |
| 54 | Acute Myocardial Infarction | 13 | 5.0 | 5.0 | signal |
| 55 | Hepatic Failure | 13 | 4.9 | 4.9 | signal |
| 56 | Grand Mal Convulsion | 4 | 4.9 | 4.9 | signal |
| 57 | Deformity | 4 | 4.9 | 4.9 | signal |
| 58 | Cerebral Infarction | 10 | 4.7 | 4.7 | signal |
| 59 | Cardiac Failure Congestive | 31 | 4.4 | 4.4 | signal |
| 60 | Dialysis | 5 | 4.0 | 4.0 | signal |
| 61 | Activities Of Daily Living Impaired | 7 | 4.0 | 4.0 | signal |
| 62 | Caesarean Section | 4 | 3.9 | 3.9 | signal |
| 63 | Adverse Event | 31 | 3.8 | 3.9 | signal |
| 64 | Haemorrhage Intracranial | 5 | 3.8 | 3.8 | signal |
| 65 | Convulsion | 17 | 3.3 | 3.4 | signal |
| 66 | Drug Exposure During Pregnancy | 10 | 3.3 | 3.3 | signal |
| 67 | Premature Delivery | 3 | 2.1 | 2.1 | no signal |